The Intersection of Biotechnology and Health Issues in IP Law: RIPL's Special Issue 2011One of the leading IP law journals in the world presents it second special symposium issue to go ebook (the 2010 issue, available as well, centered on the "green" movement). This edition of John Marshall RIPL is the new 2011 Special Issue, with seven cutting-edge articles from recognized lawyers and scholars of IP law and biotech/health sciences. Each spring, RIPL produces a symposium law review issue. In this important contribution, RIPL presents very current articles on emerging biotech research and industries, and their promotion through IP law, including patents and trademarks. Topics include encouraging biotech innovation through patent protection, the risks and advantages of DIY scientists, plain packaging of tobacco, research funding of small projects, the materiality doctrine for inequitable conduct, patenting genetic materials, EU law on patent infringement, and health care reform's effect on drug research. The volume is also useful and accessible to non-lawyers interested in these issues and the way they are affected by legal and policy decisions. |
Contents
Do You Mind My Smoking? Plain Packaging of gligarettes Under | |
The Application of Data Access Policies Designed for Qenome | |
The Flaws in 37 C F | |
Acquiring Patent Laws Meaning Through | |
The Functionality | |
The Impact of the Biosimilars Proyision of the Health glare Reform | |
Common terms and phrases
1000 Genomes Project approval argument Article 9 banc biohackers biological Biosecurity biosimilar Biotech biotechnology biotechnology companies Cefetra cigarettes common heritage data producers databases decision Directive disclosure discussion district court DIY science DIY scientists DNA sequence drugs ECJ’s EPSPS European exclusivity period FDA exclusivity garage lab gene patents genetic information glyphosate granted Human Genome inconsistent industry inequitable conduct innovation intellectual property interpretation invention isolated DNA issue last visited Mar law’s markedly different characteristics Monsanto Myriad Nat’l oversight Paris Convention patent application patent claims patent protection patent term patentability framework patentable subject matter plain packaging protein public health question quinquies reasonable examiner reference product registration regulatory restriction risk Rule 56 scope soy meal specific standard supra note synthetic biology Therasense Tobacco Control tobacco products Toronto Statement trade mark TRIPS Agreement undisclosed information